Latica News
16 articles
Lynx.MD and Schweiger Dermatology Forge Alliance to Advance Dermatology Research with Real-World Data - Lynx.MD
Lynx.MD, a healthcare data intelligence platform, has announced a new partnership with Schweiger Dermatology Group, a leading dermatology practice. This collaboration aims to create a comprehensive real-world data repository to advance dermatology research and patient care. The partnership will provide access to a vast array of dermatology patient information, including clinical images and doctors notes, to improve treatment outcomes and reduce costs. By leveraging Lynx.MDs advanced platform, which utilizes Natural Language Processing and computer vision, the partnership will enhance research capabilities and accelerate the development of new treatments. This initiative is expected to benefit MedTech, Pharma, and Life Sciences companies by providing secure access to diverse and anonymized data. The collaboration marks a significant advancement in dermatological research, promising improvements in patient care and treatment development.
Partners
Newsweek's 24 best digital health records companies in the US
Newsweek, in collaboration with Statista, recognized 24 health records companies as part of the inaugural Worlds Best Digital Health Companies 2024 list. The evaluation considered financial performance, web and app traffic data, and the impact of their products or services. This recognition highlights the achievements of these companies in the digital health sector, emphasizing their contributions to advancing healthcare technology. Companies like Abridge, Benchmark Systems, and CareCloud were among those honored, showcasing their innovation and excellence in the field.
Lynx.MD Partners with New York Gastroenterology Associates to Enhance Gastrointestinal Research Efforts (Lynx.MD) - Scope Forward
Lynx.MD, a medical data intelligence platform, has entered into a partnership with New York Gastroenterology Associates (NYGA), the largest independent gastroenterology practice in NYC. This collaboration aims to enhance gastrointestinal research by leveraging NYGAs specialized real-world data. The partnership will facilitate secure data sharing to advance therapeutic research, particularly in areas like inflammatory bowel disease, colon cancer screening, neurogastroenterology, and hepatology. NYGA will utilize Lynx.MDs data analytics platform to integrate disparate data sources, providing comprehensive data views that can optimize patient outcomes and business operations. Both organizations are committed to supporting research initiatives and driving innovation in gastroenterology, with the partnership expected to contribute significantly to advancing new treatments and improving patient care.
Partners
Lynx.MD Announces Strategic Partnership with Unio Health Partners to Expand Industry-Leading Real-World GI Data Ecosystem - Lynx.MD
Lynx.MD, a provider of real-world data technology for life sciences and medtech research, has announced a new partnership with Unio Health Partners. This collaboration aims to enhance Lynx.MD’s gastroenterology data repository and expand its capabilities in urology research. The partnership will provide a comprehensive dataset that leverages advanced NLP and computer vision techniques, improving the representation of the U.S. population in medical research. This collaboration is expected to accelerate advancements in urology and gastroenterology, offering significant opportunities for AI, MedTech, and Pharma companies by providing access to diverse datasets. The partnership aligns with Lynx.MDs mission to empower researchers with insights to advance medical progress while ensuring patient privacy.
Partners
Lynx.MD Launches Chart Abstraction AI For Unstructured Medical Data - Lynx.MD
Lynx.MD, a leader in real-world data technology for the healthcare industry, has launched Chart Abstraction AI powered by Large Language Models (LLMs). This new tool addresses the challenge of extracting actionable insights from unstructured medical data, such as x-rays and physician notes, which has traditionally been slow and inefficient. By leveraging AI and Natural Language Processing, Lynx.MDs solution allows healthcare stakeholders to efficiently identify key findings, uncover trends, and generate real-world evidence. The AI-driven tool is designed to streamline research and development efforts, improve operational efficiency, and ultimately enhance patient outcomes. The Chart Abstraction AI is currently available for preview and will soon be widely accessible on the Lynx.MD platform.
Lynx.MD Strengthens Medical Data Ecosystem with Elevate ENT Partners - Lynx.MD
Lynx.MD, a medical data intelligence platform, has formed a strategic partnership with Elevate ENT Partners to enhance otolaryngology research. Elevate ENT, with over 300 providers and 90 locations, brings a vast repository of real-world data from more than 3.5 million patients. This collaboration integrates Elevate ENTs data into Lynx.MDs secure research ecosystem, leveraging advanced AI to unlock unstructured data and provide unprecedented insights into patient outcomes. The partnership aims to drive innovation and improve patient care in otolaryngology by combining longitudinal data with cutting-edge technology. This alliance is expected to propel research forward, enabling personalized medicine and treatments in the field.
Partners
Lynx.MD Builds Massive Gastroenterology (GI) Data Repository For Research and AI Development - Lynx.MD
On January 24, 2024, Lynx.MD, a medical data intelligence platform provider, launched a comprehensive gastroenterology data repository. This repository, developed through partnerships with organizations like Gastro Health and Allied Digestive, includes extensive datasets that support research and AI development in the life sciences and medtech sectors. The platforms data library, which is continuously expanding, offers insights into various gastroenterological diseases, such as NAFLD, GERD, IBS, IBD, and colon cancer. By leveraging real-world data, Lynx.MD aims to reduce trial costs and accelerate therapeutic innovations. The companys secure data network facilitates access to real-world health data, enhancing diagnostic and therapeutic solutions while ensuring patient privacy.
Partners
Media Alert: Lynx.MD Leveraged for Study on Infliximab Optimization for IBD to be Presented at Crohn's & Colitis Congress - Lynx.MD
Prometheus Laboratories Inc., in collaboration with Lynx.MD, is set to present a study at the Crohn’s & Colitis Congress 2024. The study highlights the benefits of therapeutic drug monitoring (TDM) in optimizing infliximab dosing for IBD patients, showing reduced surgery rates and improved outcomes. This collaboration leverages Lynx.MDs comprehensive medical data platform, providing Prometheus with access to real-world treatment data. The findings support the growing evidence for personalized, TDM-driven treatments, potentially transforming IBD care and reducing healthcare costs. The presentation by Dr. Andrew Shim will take place on January 26th at the Bellagio in Las Vegas.
Partners
Lynx.MD Expands Gastroenterology Data Repository with Allied Digestive Health Collaboration - Lynx.MD
Lynx.MD, a medical data intelligence platform, has announced a strategic partnership with Allied Digestive Health (ADH), a company of Assured Healthcare Partners. This collaboration aims to expand Lynx.MDs gastroenterology data library, providing researchers and developers in the biopharma and MedTech sectors with enhanced real-world data resources. The partnership will leverage AI and privacy technologies to extract insights from healthcare datasets, facilitating early detection and preventive care in gastroenterology. The collaboration is expected to drive innovation in biopharma and MedTech, ultimately leading to advancements in patient care and the development of new healthcare solutions.
Partners
Lynx.MD and Baptist Health Innovations Collaborate to Advance Medical Research and Development
Lynx.MD, a secure medical intelligence platform, is partnering with Baptist Health Innovations at Baptist Health South Florida to establish a secure framework for sharing clinical data to catalyze medical research and development. The collaboration will provide academic and industry researchers with privacy-preserved real-world clinical data to develop, test and validate data-driven solutions that have the potential to revolutionize patient care. The collaboration will begin with Miami Cardiac & Vascular Institute and will be followed by Miami Cancer Institute, Miami Neuroscience Institute, and Baptist Health Orthopedic Care.
Partners
Lynx.MD Partners with Prometheus Labs and Gastro Health
Lynx MD Raises $12 Million Seed Funding to Reinvent Healthcare Data Collaboration Healthcare IT Today
Healthcare AI platform Lynx MD has raised $12 million in seed financing in a round led by MizMaa Ventures, with participation from New York Life Ventures, Amdocs, iAngels, Triventures, UpWest and other angel investors. The funds will be used for commercial acceleration and expansion of its customer success, sales, and marketing teams in the US and R&D team in Israel. Lynx MDs platform uses AI and machine learning to facilitate secure data sharing and optimize outcomes in healthcare organizations.
InvestmentExpand
לינקס MD בנבחרת הסטארטאפים 2020 של TheMarker
Lynx.MD, a health-tech startup, has developed a virtual environment that connects health institutions with companies in the medical and health sectors, allowing them to share information without fear of compromising privacy. The company, founded in 2019, has raised $2.5 million in funding from investors including UpWest Labs and Triventures.
Investment
In the Midst of COVID-19, How Lynx.MD's AI Solution Brings Data Forward
Lynx.MD, a healthcare data sharing company, is playing a crucial role in the fight against COVID-19. The companys technology allows healthcare organizations to share sensitive data in a fast, secure, and scalable way. This data is then made accessible to hospital analysts, decision-makers, scientists, and academics for analysis and predictive modeling. The companys approach allows hospitals to retain control of their data and decide who can access it, while ensuring patient privacy. Lynx.MD has recently launched a dedicated COVID-19 research environment on its platform to enable quick access and research of relevant data from multiple hospitals.
Expand
Portfolio Spotlight: Lynx.md
Digital health-focused company Lynx.MD has received an investment to further its mission of making healthcare data more accessible while preserving patient privacy. The companys cloud-based approach allows clinical leaders and researchers to access data within a hospitals secure environment, without the data ever leaving the hospital. This model is designed to improve research productivity, operations, and digital medicine product testing, leading to better patient outcomes and reduced healthcare costs. The team at Lynx.MD has a rich background in AI, machine learning, and the US healthcare system.
Investment
Triventures ARC fund has first closing, makes initial investment